8-K
Current Report
Avalo Therapeutics, Inc. Filed Acc 0001628280-22-029606
Acquisition or sale completed
- Item 2.01 Completion of acquisition or disposition of assets
From the SEC's structured data for this filing
Loading avtx-20221110.htm…